小児ヘルスケア市場：治療、適応症、エンドユーザー別-2025-2030年の世界予測

小児ヘルスケア市場は、2023年に1,070億1,000万米ドルと評価され、2024年には1,145億5,000万米ドルに達すると予測され、CAGR 7.53％で成長し、2030年には1,779億4,000万米ドルに達すると予測されています。

小児ヘルスケア市場は、新生児から青少年まで、小児特有の医療ニーズに合わせたさまざまなサービスを包含しています。この分野は、成人とは大きく異なる特定の発達、栄養、心理社会的要件に対応するため、不可欠です。小児ヘルスケアは治療だけでなく、予防ケア、診断、治療介入にまで及び、最終用途には病院、診療所、専門医療センターが含まれます。主な成長要因としては、医療機器や医薬品の技術進歩、子どもの健康に対する意識の高まり、小児疾患の増加などが挙げられます。利便性とアクセシビリティの向上による遠隔医療需要の急増は、利害関係者に有利な機会を提供しています。さらに、慢性疾患に対する小児科研究が盛んに行われていることも、技術革新の大きな可能性をもたらしています。しかし、厳しい規制の枠組み、高度なヘルスケアソリューションのコスト高、質の高い医療施設へのアクセス格差といった課題が、市場成長の障害となっています。業界は、特に包括的で支援的なヘルスケア政策を提唱することによって、こうした課題に対処しなければならないです。技術革新は、費用対効果の高い医療機器の開発と、十分なサービスを受けていない人々への遠隔医療ソリューションの強化に焦点を当てるべきです。さらに、診断や患者管理システムに人工知能（AI）を組み込むことで、個別化ケアを強化することができます。事業成長のためには、小児用ワクチン開発、特に急増しているウイルスの脅威に対するワクチン開発に投資し、スマートヘルス・ソリューションのためのハイテク企業との提携を模索することが賢明です。さらに、健康指標を継続的に監視し、予防的な健康管理を促進するために、小児に適応したウェアラブル健康技術の開発には大きな可能性があります。本来、小児ヘルスケア市場は競争的でありながら有望であり、継続的な研究と、世界の小児の健康状態の改善への強い推進力が特徴です。こうしたダイナミクスを活用するため、企業は技術動向や規制の変更に常に注意を払いながら、イノベーションと戦略的提携を優先させる必要があります。

市場力学：急速に進化する小児ヘルスケア市場の主要市場インサイトを公開

小児ヘルスケア市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ウイルス感染と栄養不良に起因する死亡者数の増加
  • 小児の健康促進に対する政府の支援とイニシアチブの高まり
  • 適切な治療に対する保護者の意識の高まり
• 市場抑制要因
  • 倫理的な懸念と調査対象者の少なさ
• 市場機会
  • 技術進歩における研究開発の高まり
  • 新興国における医療費の急増
• 市場の課題
  • 世界の小児科医の不足

ポーターのファイブフォース：小児ヘルスケア市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：小児ヘルスケア市場における外部からの影響の把握

外部マクロ環境要因は、小児ヘルスケア市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析小児ヘルスケア市場における競合情勢の把握

小児ヘルスケア市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス小児ヘルスケア市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、小児ヘルスケア市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨小児ヘルスケア市場における成功への道筋を描く

小児ヘルスケア市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ウイルス感染と栄養失調による死亡者数の増加
    • 小児の健康促進に向けた政府の支援と取り組みの増加
    • 適切な治療を求める親の意識の高まり
  • 抑制要因
    • 倫理的な懸念と研究対象者の少なさ
  • 機会
    • 技術進歩における研究開発の拡大
    • 新興国における医療費の急増
  • 課題
    • 世界中で小児科医が不足
• 市場セグメンテーション分析
  • 治療：さまざまな健康状態に対する免疫療法のための小児ヘルスケアの利用拡大
  • 適応症：喘息やアレルギーを管理するための小児ヘルスケアにおける効果的で年齢に適した薬剤の需要が高まっています。
  • エンドユーザー：幅広いサービスを提供する病院や診療所での小児ヘルスケアの利用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 小児ヘルスケア市場治療別

• 免疫療法
• 医薬品
• 手術

第7章 小児ヘルスケア市場適応症別

• 喘息とアレルギー
• 心臓疾患
• 遺伝性疾患
• 代謝障害

第8章 小児ヘルスケア市場：エンドユーザー別

• 外来診療センター
• ホームケア設定
• 病院・クリニック

第9章 南北アメリカの小児ヘルスケア市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の小児ヘルスケア市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの小児ヘルスケア市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • コルティカ、新たな資金調達ラウンドで7,500万米ドルを調達し、スプリングタイド・チャイルド・開発を買収
  • 小児行動医療プロバイダーのベンドヘルスが3,200万米ドルの資金調達でステルスモードから脱却
  • イプセン、アルビレオを買収し、小児肝疾患治療薬で希少疾患領域の成長を加速
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AstraZeneca PLC
• Aveanna Healthcare, LLC.
• Becton, Dickinson and Company
• bioMerieux SA
• Boehringer Ingelheim International GmbH
• Eisai Co., Ltd.
• Eli Lilly and Company
• Enviva Inc.
• Gilead Sciences, Inc.
• Glaxosmithkline PLC
• GP Pharm, S.A.
• Henin Lukinz Pvt. Ltd.
• Interim HealthCare Inc.
• Janssen Global Services LLC
• Johnson & Johnson Services, Inc.
• Medexus Pharmaceuticals, Inc.
• Medtronic PLC
• Merck KGaA
• Novartis AG
• Olympus Corporation
• ORPHELIA Pharma
• Pfizer Inc.
• Proveca Ltd.
• Royal Philips
• Sanofi S.A
• Siemens AG
• Strykar Corporation
• The Procter & Gamble Company
• Thermo Fisher Scientific, Inc.
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. PAEDIATRIC HEALTHCARE MARKET RESEARCH PROCESS
• FIGURE 2. PAEDIATRIC HEALTHCARE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PAEDIATRIC HEALTHCARE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PAEDIATRIC HEALTHCARE MARKET DYNAMICS
• TABLE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ASTHMA & ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY CARDIAC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 48. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 51. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 103. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 115. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 118. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

The Paediatric Healthcare Market was valued at USD 107.01 billion in 2023, expected to reach USD 114.55 billion in 2024, and is projected to grow at a CAGR of 7.53%, to USD 177.94 billion by 2030.

The pediatric healthcare market encompasses various services tailored to the unique medical needs of children, from newborns to adolescents. This sector is essential because it addresses specific developmental, nutritional, and psychosocial requirements that are vastly different from adults. Pediatric healthcare extends beyond treatment to preventive care, diagnostics, and therapeutic interventions, with end-use involving hospitals, clinics, and specialty care centers. Key growth influencers include technological advancements in medical devices and pharmaceuticals, rising awareness of child health, and increasing incidences of pediatric diseases. The surge in demand for telemedicine, owing to convenience and enhanced accessibility, presents a lucrative opportunity for stakeholders. Additionally, the thriving focus on pediatric research for chronic illnesses offers significant potential for innovation. However, challenges like stringent regulatory frameworks, high costs of advanced healthcare solutions, and disparities in access to quality healthcare facilities pose obstacles to market growth. The industry must address these challenges, notably by advocating for more inclusive and supportive healthcare policies. Innovation should focus on developing cost-effective medical devices and enhancing telehealth solutions to reach underserved populations. Furthermore, the integration of artificial intelligence (AI) in diagnostics and patient management systems can enhance personalized care. For business growth, investing in pediatric vaccine development, especially for emergent viral threats, and exploring partnerships with tech companies for smart-health solutions can be prudent. Additionally, there is considerable potential in developing wearable health technology adapted for children to monitor health metrics continuously, thus fostering proactive health management. In nature, the pediatric healthcare market is competitive yet promising, characterized by ongoing research and a strong drive towards better health outcomes for children globally. To harness these dynamics, companies should remain updated on technological trends and regulatory changes while prioritizing innovation and strategic collaborations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Paediatric Healthcare Market

The Paediatric Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of deaths attributed to viral infections and malnutrition
  • Rising government support and initiatives to promote pediatric health
  • Growing awareness among child parents for adequate treatment
• Market Restraints
  • Ethical concerns and small size of the study population
• Market Opportunities
  • Growing research and development in technological advancements
  • Surge in medical expenditure in emerging economies
• Market Challenges
  • Lack of pediatricians across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Paediatric Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Paediatric Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Paediatric Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Paediatric Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Paediatric Healthcare Market

A detailed market share analysis in the Paediatric Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Paediatric Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Paediatric Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Paediatric Healthcare Market

A strategic analysis of the Paediatric Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMerieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Immunotherapy, Medications, and Surgeries.
• Based on Indication, market is studied across Asthma & Allergies, Cardiac Disorders, Genetic Disorders, and Metabolic Disorders.
• Based on End-User, market is studied across Ambulatory Care Centers, Homecare Settings, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of deaths attributed to viral infections and malnutrition
    • 5.1.1.2. Rising government support and initiatives to promote pediatric health
    • 5.1.1.3. Growing awareness among child parents for adequate treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Ethical concerns and small size of the study population
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing research and development in technological advancements
    • 5.1.3.2. Surge in medical expenditure in emerging economies
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of pediatricians across the globe
• 5.2. Market Segmentation Analysis
  • 5.2.1. Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions
  • 5.2.2. Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies
  • 5.2.3. End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Paediatric Healthcare Market, by Treatment

• 6.1. Introduction
• 6.2. Immunotherapy
• 6.3. Medications
• 6.4. Surgeries

7. Paediatric Healthcare Market, by Indication

• 7.1. Introduction
• 7.2. Asthma & Allergies
• 7.3. Cardiac Disorders
• 7.4. Genetic Disorders
• 7.5. Metabolic Disorders

8. Paediatric Healthcare Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Care Centers
• 8.3. Homecare Settings
• 8.4. Hospitals & Clinics

9. Americas Paediatric Healthcare Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Paediatric Healthcare Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Paediatric Healthcare Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Cortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development
  • 12.3.2. Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding
  • 12.3.3. Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca PLC
• 3. Aveanna Healthcare, LLC.
• 4. Becton, Dickinson and Company
• 5. bioMerieux SA
• 6. Boehringer Ingelheim International GmbH
• 7. Eisai Co., Ltd.
• 8. Eli Lilly and Company
• 9. Enviva Inc.
• 10. Gilead Sciences, Inc.
• 11. Glaxosmithkline PLC
• 12. GP Pharm, S.A.
• 13. Henin Lukinz Pvt. Ltd.
• 14. Interim HealthCare Inc.
• 15. Janssen Global Services LLC
• 16. Johnson & Johnson Services, Inc.
• 17. Medexus Pharmaceuticals, Inc.
• 18. Medtronic PLC
• 19. Merck KGaA
• 20. Novartis AG
• 21. Olympus Corporation
• 22. ORPHELIA Pharma
• 23. Pfizer Inc.
• 24. Proveca Ltd.
• 25. Royal Philips
• 26. Sanofi S.A
• 27. Siemens AG
• 28. Strykar Corporation
• 29. The Procter & Gamble Company
• 30. Thermo Fisher Scientific, Inc.
• 31. Viatris Inc.